Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study

AIMS: This study was designed to investigate the biochemical and physiological covariates or comedications that affect the pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia (CP CML). METHODS: Pharmacokinetic data were analyzed in 371 patients receiving 40...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schmidli, H, Peng, B, Riviere, G-J, Capdeville, R, Hensley, M, Gathmann, I, Bolton, A E, Racine-Poon, A
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Science Inc 2005
Assuntos:
Pharmacokinetics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884912/
https://ncbi.nlm.nih.gov/pubmed/15963092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2005.02372.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares